tradingkey.logo

tradingkey.logo
怜玢


Prenetics Global Ltd

PRE
りォッチリストに远加
22.930USD
+0.220+0.97%
終倀 09-24 16:00ET
393.02M時䟡総額
損倱額盎近12ヶ月PER

Prenetics Global Ltdに぀いお 䌁業名

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.

Prenetics Global Ltd プロフィヌル


䌁業コヌドPRE
䌚瀟名Prenetics Global Ltd
䞊堎日Jul 06, 2021
最高経営責任者「CEO」Kwok (Samantha)
埓業員数285
蚌刞皮類Ordinary Share
決算期末Jul 06
本瀟所圚地Unit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
郜垂
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Hong Kong
郵䟿番号- -
電話番号85222109588
りェブサむトhttps://ir.prenetics.com/
䌁業コヌドPRE
䞊堎日Jul 06, 2021
最高経営責任者「CEO」Kwok (Samantha)

Prenetics Global Ltdの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
Dr. Darshan Shah
Dr. Darshan Shah
Independent Director
Independent Director
4.51K
--
Dr. Darshan Shah
Dr. Darshan Shah
Independent Director
Independent Director
4.51K
--
Dr. Darshan Shah
Dr. Darshan Shah
Independent Director
Independent Director
4.51K
--
Mr. Yin Pan (Ben) Cheng
Mr. Yin Pan (Ben) Cheng
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
167.42K
+17.16%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%
Mr. Hudson Leogrande
Mr. Hudson Leogrande
Independent Director
Independent Director
6.00K
+33.33%

よくある質問

Prenetics Global Ltdの䞊䜍5名の株䞻は誰ですか


Prenetics Global Ltdの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Sheng Wu (Danny) Yeung

Prenetics Global LtdPREの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Prenetics Global Ltdの株匏を保有しおいる機関は46瀟あり、保有株匏の総垂堎䟡倀は玄1.76Mで、党䜓の11.33%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-778478.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。